Anji Reddy

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

8 documents for Anji Reddy

- Dr. K. Anji Reddy Joins WaterHealth International's Board of Directors.
LAKE FOREST, Calif. -- Chairman of India's Second Largest Pharmaceutical Company -- Dr. Reddy's Laboratories Limited -- Enhances Industry and Geograph...
- Business Wire
- February 28, 2005
- A Hermeneutical Approach to Understanding Entrepreneurial Failure
This paper reports an investigation of entrepreneurial failure using hermeneutic analysis of five entrepreneurship narratives. The data used in this study was collected between 2002 and 2005. The research focuses on entrepreneurial orientation anddefines entrepreneurs as individuals who can "see what is not there." The researchers adopted "a deviation from the entrepreneurs' desired expectations" as their working definition of entrepreneurial failure. The paper progresses throughfour levels of interpretation in the development of theoretical understanding of personal and organizational learning from failure. The researchers found that individuals and organizations can learn from failure and thus improve chances of ultimate success. However, sometimes individuals and organizations do not...

...Anji Reddy. The third level of interpretation is the ap...
- Academy of Entrepreneurship Journal
- Vol. 14 Nbr. 1/2, January 2008
- Dr. Reddy's Announces the Formation of Perlecan Pharma; Perlecan Pharma Raises USD 52.5 Million as Initial Equity Capital; Perlecan Pharma: India's First Integrated Drug Development Company.
...Anji Reddy, Chairman, Dr. Reddy's Laboratories, said, "...
- Business Wire
- September 28, 2005

- Dr. Reddy's Signs Definitive Agreement with 3i for the Strategic Acquisition of betapharm.
.... Commenting on the acquisition, Dr Anji Reddy, Chairman, Dr. Reddy's Laboratories, said, "...
- Business Wire
- February 16, 2006
- Dr. Reddy's Q3 FY09 Revenue at Rs. 18,401 million, EBITDA at Rs. 3,453 million, PAT at Rs. 1,924 million.
...Palepu's resignation from the Board, Dr. Anji Reddy, Chairman said that, "Krishna was an outstan...
- Business Wire
- January 20, 2009
- Dr Reddy's launches Reditux(TM) - Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma.
.... Talking at the technical session Dr Anji Reddy, Chairman, Dr. Reddy's Laboratories said "Dr...
- Business Wire
- April 30, 2007
- Dr. Reddy's Laboratories Limited Announce Agreement For Utilizing Incyte LifeSeq Gold Online.
...Dr. K. Anji Reddy, Chairman of Dr. Reddy's Laboratories Limite...
- Business Wire
- November 20, 2001
- Dr. Bruce Carter, President and CEO, ZymoGenetics Inc., Is Named to the Board of Directors of Reddy US Therapeutics, Inc.
...Anji Reddy, Chairman of the Board. He further added, "H...
- Business Wire
- April 23, 2001